Investigation on Novel E/Z 2-Benzylideneindan-1-One-Based Photoswitches with AChE and MAO-B Dual Inhibitory Activity
Molecules · 2023
DOI: 10.3390/molecules28155857 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Marco Paolino und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via A. Moro 2, I-53100 Siena, Italy. Hauptthemen laut MEDLINE: Monoamine Oxidase, Alzheimer Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MUR, PRIN.
Abstract (Originalsprache)
The multitarget therapeutic strategy, as opposed to the more traditional ‘one disease-one target-one drug’, may hold promise in treating multifactorial neurodegenerative syndromes, such as Alzheimer’s disease (AD) and related dementias. Recently, combining a photopharmacology approach with the multitarget-directed ligand (MTDL) design strategy, we disclosed a novel donepezil-like compound, namely 2-(4-((diethylamino)methyl)benzylidene)-5-methoxy-2,3-dihydro-1H-inden-1-one (1a), which in the E isomeric form (and about tenfold less in the UV-B photo-induced isomer Z) showed the best activity as dual inhibitor of the AD-related targets acetylcholinesterase (AChE) and monoamine oxidase B (MAO-B). Herein, we investigated further photoisomerizable 2-benzylideneindan-1-one analogs 1b–h with the unconjugated tertiary amino moiety bearing alkyls of different bulkiness and lipophilicity. For each compound, the thermal stable E geometric isomer, along with the E/Z mixture as produced by UV-B light irradiation in the photostationary state (PSS, 75% Z), was investigated for the inhibition of human ChEs and MAOs. The pure E-isomer of the N-benzyl(ethyl)amino analog 1h achieved low nanomolar AChE and high nanomolar MAO-B inhibition potencies (IC50s 39 and 355 nM, respectively), whereas photoisomerization to the Z isomer (75% Z in the PSS mixture) resulted in a decrease (about 30%) of AChE inhibitory potency, and not in the MAO-B one. Molecular docking studies were performed to rationalize the different E/Z selectivity of 1h toward the two target enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via A. Moro 2, I-53100 Siena, Italy.
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, I-70125 Bari, Italy.
ORCID-Profile: Marco Paolino, Modesto de Candia, Rosa Purgatorio, Marco Catto, Mario Saletti, Anna Rita Tondo, Orazio Nicolotti, Andrea Cappelli, Antonella Brizzi, Federico Corelli, Cosimo D Altomare
Förderung
- MUR
- PRIN
Zitieren
APA
Paolino, M., de Candia, M., Purgatorio, R., Catto, M., Saletti, M., Tondo, A. R., Nicolotti, O., Cappelli, A., Brizzi, A., Mugnaini, C., Corelli, F., & Altomare, C. D. (2023). Investigation on Novel E/Z 2-Benzylideneindan-1-One-Based Photoswitches with AChE and MAO-B Dual Inhibitory Activity. Molecules. https://doi.org/10.3390/molecules28155857
Vancouver
Paolino M, de Candia M, Purgatorio R, Catto M, Saletti M, Tondo AR, et al. Investigation on Novel E/Z 2-Benzylideneindan-1-One-Based Photoswitches with AChE and MAO-B Dual Inhibitory Activity. Molecules. 2023. doi:10.3390/molecules28155857
BibTeX
@article{Paolino2023,
author = {Paolino, Marco and de Candia, Modesto and Purgatorio, Rosa and Catto, Marco and Saletti, Mario and Tondo, Anna Rita and Nicolotti, Orazio and Cappelli, Andrea and Brizzi, Antonella and Mugnaini, Claudia and Corelli, Federico and Altomare, Cosimo D},
title = {Investigation on Novel E/Z 2-Benzylideneindan-1-One-Based Photoswitches with AChE and MAO-B Dual Inhibitory Activity},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28155857}
}
EUVIMED